The multinational conglomerate Fujifilm will invest $1.6 billion to improve and ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies. Most of the investment will focus on a site in Hillerød, Denmark. A site in College Station, Texas, will also benefit from a funding injection. The investment will increase the…
Recipharm sells plants in France and the UK
Recipharm has sold a solid-dose manufacturing plant in Fontaine-lès-Dijon, France to Astrea Pharma, a new contract development and manufacturing organization (CDMO). Recipharm also announced that Pharmaron Beijing Co. has acquired Aesica Pharmaceuticals Ltd, which Recipharm had acquired about a year ago. Historically, the plant in France has focused on manufacturing and packaging tablets and capsules.…